| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.64B | 3.28B | 4.29B | 2.69B | 2.21B | 1.80B |
| Gross Profit | 2.51B | 2.30B | 3.38B | 1.89B | 1.54B | 1.17B |
| EBITDA | 3.32B | 2.93B | 3.79B | 3.16B | 4.13B | 382.00M |
| Net Income | 1.63B | 1.48B | 2.23B | 1.80B | 2.89B | 189.00M |
Balance Sheet | ||||||
| Total Assets | 59.70B | 57.93B | 54.07B | 48.47B | 42.37B | 35.12B |
| Cash, Cash Equivalents and Short-Term Investments | 2.64B | 4.63B | 4.92B | 3.41B | 2.89B | 2.67B |
| Total Debt | 26.76B | 25.89B | 22.75B | 19.33B | 15.27B | 11.82B |
| Total Liabilities | 35.27B | 34.10B | 30.50B | 26.37B | 21.60B | 16.99B |
| Stockholders Equity | 24.41B | 23.81B | 23.54B | 22.07B | 20.74B | 18.10B |
Cash Flow | ||||||
| Free Cash Flow | 1.52B | 1.58B | 1.17B | 1.69B | 1.32B | 649.00M |
| Operating Cash Flow | 1.74B | 1.82B | 1.37B | 1.75B | 1.36B | 941.00M |
| Investing Cash Flow | -3.53B | -3.14B | -1.47B | -2.82B | -2.99B | -1.17B |
| Financing Cash Flow | 3.08B | 1.07B | 1.68B | 1.57B | 1.89B | 48.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | 12.58B | 11.33 | ― | 5.14% | 4.64% | 57.07% | |
76 Outperform | 17.93B | 10.39 | ― | 1.12% | 8.54% | 74.58% | |
76 Outperform | 20.28B | 12.64 | ― | 1.78% | 14.47% | 39.39% | |
76 Outperform | 10.22B | 15.27 | ― | 1.15% | 20.53% | 145.07% | |
68 Neutral | 8.62B | 11.90 | ― | ― | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | $42.24B | 25.85 | 6.66% | 1.89% | -14.20% | -20.29% |